Showing results (111-120 of 153) with videos related to
Sort By:
Pageof 16
Cancer Research|May 1, 2014
Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30Eva Schlecker, Nathalie Fiegler, Annette Arnold, et al.Cancer Research|May 13, 2010
E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancerDaniel Reimer, Michael Hubalek, Svenja Riedle, et al.Cellular and Molecular Life Sciences : CMLS|July 5, 2012
CD24 controls Src/STAT3 activity in human tumorsNiko P Bretz, Alexei V Salnikov, Claudia Perne, et al.Biochemical and Biophysical Research Communications|March 3, 2009
Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinomaPaul Gutwein, Anja Schramme, Beren Voss, et al.Journal for Immunotherapy of Cancer|March 18, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing miceRebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, et al.BMC Cancer|February 15, 2017
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancerHans-Peter Sinn, Andreas Schneeweiss, Marius Keller, et al.Journal of Reproductive Immunology|November 29, 2024
Expression of the mucin-like glycoprotein CD24 and its ligand siglec-10 in placentas with acute and post SARS-CoV-2 infectionMarina C Seefried, Johanna Mittelberger, Manuela Franitza, et al.Histochemistry and Cell Biology|November 26, 2024
PD-L1 expression and characterization of its carrier macrophages in placentas with acute and specifically post-SARS-CoV-2 infectionMarina C Seefried, Johanna Mittelberger, Manuela Franitza, et al.The Journal of Biological Chemistry|November 15, 2013
Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signalingNiko P Bretz, Johannes Ridinger, Anne-Kathleen Rupp, et al.Breast Cancer Research and Treatment|January 15, 2013
CD24 polymorphisms in breast cancer: impact on prognosis and riskKatharina Buck, Sarah Hug, Petra Seibold, et al.Pageof 16